A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Recruiting · NCT06942442 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, clear cell sarcoma, connective tissue neoplasm, neoplasm, sarcoma | Recruiting | Phase 2 | 2026-10-02 | NCT06942442 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
| Royal Marsden NHS Foundation Trust | 89 |
| Sarcoma Alliance for Research through Collaboration | 7 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Royal Marsden | London | United Kingdom | 3 |
| University of Southern California - Norris Cancer Center | Los Angeles | United States | 1 |